Skip to content

A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis

A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis 1

Seventeen patients with palmoplantar pustular psoriasis and three with hyperkeratotic psoriasis of palms and soles were treated with either PUVA-etretinate (1 mg/kg) or PUVA-placebo. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. PUVA-Etretinate Therapy in Chronic Plaque and Palmar Plantar Pustular Psoriasis. PUVA is an effective treatment for chronic plaque psoriasis1 (CPP) and palmar plantar pustular psoriasis (PPPP). We have compared PUVA etretinate and PUVA-placebo in two randomized, double-blind studies of CPP and PPPP.

A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis 2Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Chronic palmoplantar pustular psoriasis (PPP) is a disabling condition characterized by recurrent crops of sterile pustules on a background of erythema, fissuring and scaling. Unlike systemic PUVA, studies have failed to demonstrate the superiority of topical PUVA over placebo,10,11 although a study comparing topical with systemic PUVA found no significant difference between them. Topical PUVA, etretinate, and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections. PUVA-etretinate therapy for pustulosis palmoplantaris: a placebo-controlled comparative trial. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis.

Psoriasis is a common, chronic condition characterized by red, scaly, and indurated (thick) skin lesions. Palmoplantar pustulosis (PPP) is an uncommon chronic skin disorder characterized by recurrent eruptions of pustules on the palms and soles (). S. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Vallat, VP, Gilleaudeau, P, Battat, L et al, PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. T. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis.

References In Consensus Conference: Acitretin In Combination With Uvb Or Puva In The Treatment Of Psoriasis

A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis 3317 fully in combination with PUVA, 8 etretinate, 13 and methotrexate. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Four RCTs compared acitretin and PUVA (rePUVA) with placebo and PUVA, and showed acitretin-PUVA combination to be more effective than PUVA alone, reducing the number of PUVA treatments, exposure to UVA and the clinical scores. Acitretin and etretinate in the treatment of palmoplantar pustulosis: A double blind comparative trial. After identifying the co-authorships of documents on psoriasis indexed in the Medline database (1942 2013), various bibliometric indicators were obtained, including the average number of authors per document and degree of multi-authorship over time. Clustering coefficient: calculated according to the measure proposed by Watts and Strogatz, as the average of the local clustering coefficients of all the nodes, where the local clustering coefficient of each node is the proportion of real connections between it and its neighbors, compared with the number of all links that could possibly exist between them 16.

Psoriasis